The MD Magazine Acne condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.


Another Milestone for Acne Vulgaris: New Phase 3 Clinical Trial Begins
Researchers initiated a new phase 3 clinical trial for topical agent olumacostat glasaretil, a potential treatment for acne vulgaris.
From observations about butter and questions about acne to findings about flu shots and platypus venom, dozens of fascinating studies came out in 2016 regarding the disease.
Robert G. Micheletti, MD, discusses the importance of disease staging to determine treatment for hidradenitis suppurativa and lifestyle changes to help control symptoms.
Robert G. Micheletti, MD, outlines the presentation and disease characteristics that lead to a diagnosis of hidradenitis suppurativa.
Robert G. Micheletti, MD, discusses the pathophysiology and risk factors associated with hidradenitis suppurativa.
Robert G. Micheletti, MD, provides an overview of hidradenitis suppurativa, including symptoms and quality of life issues.
Patients battling acne can now add a new medication to their regimen. The FDA has approved the over-the-counter (OTC) topical gel adapalene (Differin Gel 0.1%/Galderma Laboratories) for the treatment of acne in people 12 years or older.
While cleansers and other at-home face masks can do wonders for acne and facial scarring, home remedies for skin cancer should be avoided at all costs.
Although popular acne treatment isotretinoin (Accutane) has been known to cause birth defects, many women still fail to follow simple contraception rules.

Most Popular


$vacMongoViewPlus$ $vAR$